Skip to main navigation Skip to main content
Home
Menu
  • Join Our Mailing List
  • Contact Us
  • About
    • About BBCIC
      • BBCIC FAQs
    • Governance
      • Board of Managing Directors
      • Communications Committee
      • Steering Committee
      • Science Committee
    • Partners
    • Contact
  • Research
    • Approach
    • Range of Research
    • Our Research
    • Publications & Presentations
  • News & Events
    • BBCIC Calendar
    • BBCIC News
    • Quarterly Newsletters
  • Resources
    • BBCIC Resources
    • FDA Guidance
    • Biosimilars Facts
  • Search
 
Enter your keyword(s)

Breadcrumb

  1. BBCIC
  2. Resources
  3. FDA Guidance
  4. Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product

Main navigation

  • About
    • About BBCIC
    • Governance
    • Partners
    • Contact
  • Research
  • News & Events
  • Resources
    • BBCIC Resources
    • FDA Guidance
    • Biosimilars Facts
  • Search

Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product

Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product is the final version of a draft guidance for industry originally released in 2012. It describes the Agency’s current thinking about factors to consider when demonstrating that a proposed therapeutic protein product is highly similar to a reference product, with recommendations focused on scientific and technical information related to chemistry, manufacturing, and controls (CMC). In particular, this document provides guidance on analytical studies relevant to assessing whether the proposed product and a reference product are highly similar.

The full document is available on the FDA website.

Tags:

Why BBCIC?
Learn more about BBCIC and what we do.
Download Our Fact Sheet
Join BBCIC
Help us monitor use, impact, safety, and clinical effectiveness of biologics including biosimilars.
Participate in BBCIC

Contact Us

Send a Message

Address

675 N Washington Street
Suite 220
Alexandria, VA 22314

Phone

703.684.2600

Menu

  • About
  • Research
  • News & Events
  • Resources
  • Search
BBCIC Logo
  • Antitrust
  • Privacy Policy
  • Disclaimer


© 2023 Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

  • About
    • About BBCIC
      • BBCIC FAQs
    • Governance
      • Board of Managing Directors
      • Communications Committee
      • Steering Committee
      • Science Committee
    • Partners
    • Contact
  • Research
    • Approach
    • Range of Research
    • Our Research
    • Publications & Presentations
  • News & Events
    • BBCIC Calendar
    • BBCIC News
    • Quarterly Newsletters
  • Resources
    • BBCIC Resources
    • FDA Guidance
    • Biosimilars Facts
  • Search